The 20 Best Muscle Invasive Bladder Cancer Doctors Near Me in Summit, NJ

Joshua Fiske is a Urologist practicing medicine in Westfield, New Jersey. Dr. Fiske is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Perirenal Abscess, Carbuncle, Boils, and Ureteroscopy. Dr. Fiske is board certified in American Board Of Urology. Dr. Fiske is currently accepting new patients.

John Gianis is a Urologist practicing medicine in Summit, New Jersey. Dr. Gianis is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Enlarged Prostate (BPH), Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer. Dr. Gianis is board certified in American Board Of Urology. Dr. Gianis is currently accepting new patients.

Dr. Naeem Rahman is the medical director for Atlantic Medical Group Urology in Union and Somerset Counties. A board-certified urologist, he specializes in the treatment of urological cancers, with a focus on prostate and bladder cancer, as well as diseases and disorders of the urinary tract in both men and women. With nearly 20 years of professional experience, Dr. Rahman is known for his expertise in nerve-sparing surgery, robotic surgery, open surgery, and advanced focal therapies like cryotherapy and ablation for salvage prostate cancer. He is committed to restoring normal function and improving the quality of life for his patients, offering a comprehensive, multidisciplinary approach to prostate cancer treatment, including active surveillance and a focus on men’s sexual health.Dr. Rahman delivers concierge-level care, providing both surgical and clinical excellence while maintaining a warm, compassionate approach. He served as chief of Urology and director of Robotic Surgery at Vassar Brothers Medical Center in Poughkeepsie, NY, overseeing nearly 1,000 robotic and laparoscopic procedures. In addition, he directed an advanced prostate cancer clinic, providing the latest treatment options for patients with disease progression. His practice offers a robust male sexual health medicine program, with specialized care for erectile dysfunction (ED).Dedicated to advancing state-of-the-art therapeutics, Dr. Rahman has served as a primary investigator on several clinical trials for bladder and prostate cancer. He is a member of the American Urological Association and the Society of Robotic Surgery. After earning his degree from Wake Forest University School of Medicine, Winston-Salem, NC, Dr. Rahman completed residency programs in surgery and urology at Eastern Virginia Medical School in Norfolk, VA. He is an assistant clinical professor at New York Medical College, Valhalla, NY. Dr. Rahman is also a participating provider of the Atlantic Accountable Care Organization. Dr. Rahman is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Bilateral Hydronephrosis, Ureteroscopy, and Prostatectomy. Dr. Rahman is board certified in American Board Of Urology. Dr. Rahman is currently accepting new patients.

The relationship between patient and physician is a partnership and the best medicine is practiced as part of a team-based approach with patients, their families and their other physicians. As an experienced fellowship-trained, minimally-invasive urologic oncologic surgeon, my role as your advisor is to provide the most effective medical and surgical techniques for the management of prostate, bladder, kidney, testicular and adrenal cancers. This not only takes into account the disease process, but importantly recognizes the effect on quality-of-life on both patients and caregivers during and following treatment. Education and communication are the hallmarks of ensuring that we are part of a successful team together. Dr. Prasad is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Urothelial Cancer, Ureteroscopy, and Bladder Reconstruction. Dr. Prasad is board certified in American Board Of Urology. Dr. Prasad is currently accepting new patients.

It’s important to me to connect with my patients on a personal level, which helps me better understand their problems and concerns. I’m genuinely interested in them and their families and improving their quality of life, and I encourage everyone in the practice to treat patients with that same level of compassion. My patients perceive me as an experienced, compassionate urologic surgeon they can rely on. I enjoy treating the entire range of urologic disorders, with a special interest in oncology and kidney problems. Dr. Taylor is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Familial Prostate Cancer, Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Taylor is board certified in American Board Of Urology. Dr. Taylor is currently accepting new patients.

My experience as a fellowship-trained urologic oncologist has taught me that optimizing medical care is a combination of incorporating evidence-based practices with a strong multidisciplinary team. I have always had deep compassion for patients as well as a curiosity about the science behind disease diagnosis, treatment, and prevention. There is great potential to both cure and improve the quality of life for patients with urologic disease. My training with leaders in the field of open and robotic surgery, pharmacotherapy, and integrative treatments has given me a dynamic toolset to address all of a patient’s needs. I offer minimally invasive surgery for a wide variety of malignant and benign urologic conditions to help patients recover quickly and allow them to spend more time on things that matter to them. Dr. Taylor is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Muscle Invasive Bladder Cancer, Familial Prostate Cancer, Nephrectomy, and Cystectomy. Dr. Taylor is board certified in American Board Of Urology. Dr. Taylor is currently accepting new patients.

William Rafelson, MD, MBA, is a fellowship-trained hematologist-oncologist with Atlantic Medical Group (AMG). Board-certified in Internal Medicine, Hematology, and Medical Oncology by the American Board of Internal Medicine, he has a focus in the management of advanced genitourinary cancers (cancers arising from the bladder, urinary tract, kidney, prostate, or testes), and treats a range of hematologic and oncologic disorders. He believes in providing compassionate care and uses a shared decision-making approach in tailoring the right treatment regimen, whether that is chemotherapy, hormone therapy, or immunotherapy to treat the patient’s disease.After earning his medical degree at the UMDNJ-Robert Wood Johnson Medical School at Camden, NJ, Dr. Rafelson completed an internal medicine residency at The Warren Alpert Medical School of Brown University, Providence, RI, served as a National Institutes of Health (NIH) T32 post-doctoral research fellow at Rhode Island Hospital, also in Providence, followed by fellowship in Hematology/Oncology, again at Warren Alpert School of Medicine. He also holds an MBA from the Heller School for Social Policy and Management, Brandeis University, Waltham, MA. Prior to joining AMG, he served as assistant attending in the Solid Tumor Genitourinary Oncology service at Memorial Sloan Kettering Cancer Center in Middletown, NJ, and served on the inpatient genitourinary service in Memorial Hospital in New York City.The author of multiple publications in peer-reviewed medical journals, Dr. Rafelson has also written several chapters in medical textbooks, including Ferri’s Clinical Advisor. He won a National Research Service Postdoctoral Award from the NIH and was one of just 15 medical oncologists nationally to be selected for a Rising Star Award from Castle Connolly. He was selected as one of “Jersey’s Best” medical oncologists in 2022 and 2023.Prior to joining AMG, Dr. Rafelson served as Instructor of Medicine and, later, Assistant Professor of Medicine at Weill Cornell Medical College, Cornell University, New York City, teaching first- and second-year medical students. He is a member of the American Society for Clinical Oncology and the American College of Physicians. He attends the MSKCC Annual Hematology-Oncology Review as well as ASCO annual conferences yearly to apply the most up-to-date information in his specialty. Dr. Rafelson is a participating provider of the Atlantic Accountable Care Organization. Dr. Rafelson is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and Urothelial Cancer. Dr. Rafelson is board certified in American Board Of Internal Medicine. Dr. Rafelson is currently accepting new patients.

"As part of the radiation oncology team at Overlook Medical Center, Dr. Kornmehl offers patients more than 30 years of experience in all aspects of her field. She received her medical degree from SUNY Downstate in Brooklyn, then pursued her internship in internal medicine at Brookdale Hospital Medical Center and her radiation therapy residency at SUNY Downstate Medical Center, both located in Brooklyn. Dr. Kornmehl has served as a clinical assistant professor in radiation oncology at several universities including UMDNJ-New Jersey Medical School, Staten Island University Hospital School of Radiologic Sciences, Hahnemann University Hospital, and Rutgers-Robert Wood Johnson Medical School, where she remains on faculty. She has also served in leadership roles at various hospitals including UMDNJ University Hospital, Brick and Point Pleasant Hospitals, and Monmouth Medical Center, where she was appointed Director of Radiation Oncology. Named repeatedly as a New Jersey Monthly Magazine Top Doctor, Dr. Kornmehl has been recognized for several academic, research and professional accomplishments. Her work has appeared in numerous medical journals and publications, and she is the author of the critically acclaimed consumer health book, ""The Best News about Radiation Therapy."" Dr. Kornmehl has also appeared on television and radio to raise awareness about topics relating to cancer, and she has been an invited guest speaker at national lectures and conferences. Although passionate about her life's work, in her downtime this Brooklyn native enjoys yoga, travelling and all things Elvis.". Dr. Kornmehl is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer. Dr. Kornmehl is currently accepting new patients.

With his many speaking engagements and commitment to education, Dr. Neil Morganstein has a reputation as a leader in the treatment of hematological and oncological issues. He is a national speaker in the area of multiple myeloma, as well as co-chair of a video conference on the management of patients with multiple myeloma. He has a special interest in lung cancer and multiple myeloma, and has published and presented several peer-reviewed articles, posters and abstracts at regional and national oncology meetings. These have focused on multiple myeloma, lymphoma, prostate cancer, gastric cancer, and hematological complications during pregnancy.As an involved and committed oncologist at Overlook Medical Center’s Carol G. Simon Cancer Center, Dr. Morganstein gives several lectures a year educating medical students. He teaches the hematology board review course for the American College of Physicians, as well as the hematology and oncology course for residents at Rutgers University. In addition, he thoroughly enjoys working with medical students in the hospital.Dr. Morganstein completed his hematology and oncology fellowship at Robert Wood Johnson University Hospital of New Brunswick, New Jersey, where he also finished his residency training, while serving as chief resident. He is board-certified in medical oncology, hematology and internal medicine and maintains membership in many distinguished organizations, including the American Society of Clinical Oncologists and the American Society of Hematologists. Dr. Morganstein is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration. Dr. Morganstein is board certified in American Board Of Internal Medicine. Dr. Morganstein is currently accepting new patients.

Deepika Jain, MD, FASN, FNKF, is a fellowship-trained nephrologist with Atlantic Medical Group (AMG). Board-certified in internal medicine and nephrology by the American Board of Internal Medicine, Dr. Jain specializes in diagnosing, treating and managing acute and chronic kidney conditions and diseases. She also treats related issues like high blood pressure (hypertension), dialysis and post renal transplant care.After earning her medical degree at the Lady Hardinge Medical College, University of Delhi in India, Dr. Jain completed her residency in internal medicine at the University of Missouri School of Medicine, Columbia, MO, where she also served as a clinical instructor. She followed that with a fellowship in clinical nephrology, in the Renal-Electrolyte Division at the University of Pittsburgh Medical Center in Pennsylvania.Following her move to New Jersey, Dr. Jain joined Medical Diagnostic Associates Nephrology after several years of active practice in Hudson County. She is the author of numerous papers in peer-reviewed medical journals on various kidney diseases and health literacy in dialysis. She has presented at national and international conferences over the years and has been on the panel to judge abstracts submitted to American Society of Nephrology meetings.Dr. Jain is a distinguished member and Fellow of National Kidney Foundation, where she serves on its Medical Advisory Board, and the American Society of Nephrology, and a member of the International Society for Peritoneal Dialysis. She is fluent in both English and Hindi. Dr. Jain is a participating provider of the Atlantic Accountable Care Organization. Dr. Jain is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses End-Stage Renal Disease (ESRD), Acute Kidney Failure, Chronic Kidney Disease, and Acute Tubular Necrosis. Dr. Jain is currently accepting new patients.

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Colorectal Cancer, and Bone Marrow Aspiration. Dr. Strauss is board certified in American Board Of Internal Medicine. Dr. Strauss is currently accepting new patients.

Jayram Krishnan is an Oncologist practicing medicine in Berkeley Heights, New Jersey. Dr. Krishnan is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Stuart Leitner is an Oncologist practicing medicine in Livingston, New Jersey. Dr. Leitner is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Leitner is currently accepting new patients.

Cornelius Mccarthy is a Radiologist practicing medicine in Livingston, New Jersey. Dr. Mccarthy is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Ascites, Gastric Lymphoma, Muscle Invasive Bladder Cancer, Pleurisy, and Gastrostomy.

Karleung Siu is a Hematologist and an Oncologist practicing medicine in Florham Park, New Jersey. Dr. Siu is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Anemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Siu is board certified in American Board Of Internal Medicine. Dr. Siu is currently accepting new patients.

Mark Miller is a Urologist practicing medicine in Westfield, New Jersey. Dr. Miller is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Carbuncle, and Ureteroscopy. Dr. Miller is board certified in American Board Of Urology. Dr. Miller is currently accepting new patients.

Alon Mass is a Urologist practicing medicine in Westfield, New Jersey. Dr. Mass is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Urinary Tract Infection (UTI), Urinary Tract Infection in Children, UPJ Obstruction, Ureteroscopy, and Nephrectomy. Dr. Mass is board certified in American Board Of Urology. Dr. Mass is currently accepting new patients.

Ashish Ashvin Shah, DO, MSc, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, he has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Shah’s clinical interests span a wide spectrum, from acute and chronic leukemia to lymphoma, multiple myeloma, myelodysplastic disease, and various types of cancer, including lung, colorectal, breast, ovarian, and neuroendocrine tumors. He has extensive knowledge and experience in these conditions.After earning his osteopathic medicine degree from Philadelphia College of Osteopathic Medicine, Dr. Shah completed an internal medicine residency at Robert Wood Johnson University Hospital in New Brunswick, NJ. He completed a hematology and oncology fellowship also at Robert Wood Johnson. Previously, he completed a Master of Science (MSc) degree in neuroscience at Southern Connecticut State University.Prior to joining AMG, Dr. Shah served as director of leukemia/lymphoma services and co-director of the adolescent and young adult oncology program at Lehigh Valley Health Network in Bethlehem, Pennsylvania for seven years. He also served as a clinical assistant professor of medicine at the University of South Florida’s Morsani College of Medicine in Tampa. Dr. Shah joined ACOHA in 2016.Dr. Shah is a member of the American Society of Clinical Oncology, American Society of Hematology, American Osteopathic Association, and American Association of Physicians from India. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Iron Deficiency Anemia, Large-Cell Immunoblastic Lymphoma, Childhood Iron Deficiency Anemia, Acute Myeloid Leukemia (AML), and Bone Marrow Aspiration. Dr. Shah is board certified in American Board Of Internal Medicine. Dr. Shah is currently accepting new patients.

Charlesse Pondt-Huannou, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, she has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Pondt-Huannou is dedicated to providing the highest quality of care for her patients. She listens thoroughly and takes time to carefully explain everything involved in the patient’s individualized plan of care.Dr. Pondt-Huannou is an expert in the fields of breast and gynecological cancers; hematologic malignancies (myeloma and chronic leukemias and lymphomas); managing complex hematological issues in high-risk obstetric and gynecologic patients; sickle cell disease; and anemia. She is also experienced in the management of liver, bladder, colon, cervical, lung, prostate and pancreatic cancers. She joined ACOHA immediately out of fellowship in 2014.After earning her medical degree from UMDNJ New Jersey Medical School in Newark, NJ, Dr. Pondt-Huannou completed an internal medicine residency at Memorial Sloan-Kettering Cancer Center concurrent with a residency at New York-Presbyterian, Cornell Medical Center, both in New York City. She completed a hematology and oncology fellowship at Albert Einstein College/Montefiore and Jacobi medical centers and Lincoln Hospital in the Bronx, NY.Dr. Pondt-Huannou is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association, and the National Medical Association. She also serves on numerous committees including the Sickle Cell Management Committee at Overlook Medical Center. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Huannou is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Childhood Iron Deficiency Anemia, Anemia, Deep Vein Thrombosis, and Myelodysplastic Syndrome (MDS). Dr. Huannou is board certified in American Board Of Internal Medicine. Dr. Huannou is currently accepting new patients.

Anthony R. Lutz, APN, CUNP, has more than 10 years of specialized expertise in caring for new and follow-up patients with conditions related to the genitourinary system, including survivorship care for urologic cancers, BPH, urinary retention, kidney stones, erectile dysfunction, hematuria, prostatitis, scrotal pain, urinary tract infections, sexually transmitted infections, voiding dysfunction, and other urologic diagnoses. He is licensed to order and interpret lab work, order and interpret imaging studies, and prescribe medications. Part of Atlantic Medical Group (AMG), he is board-certified as an adult-gerontology primary care nurse practitioner by the American Academy of Nurse Practitioners (AANP), and as a certified urologic nurse practitioner (CUNP) by the Certification Board for Urologic Nurses and Associates (CBUNA).After earning his bachelor of science in nursing at Columbia University School of Nursing in New York City, Anthony attained his master of science in nursing as an adult-gerontology primary care nurse practitioner from the same school. He then went on to complete a year-long fellowship in urology for advanced practice providers at the Center for Advanced Practice at Atrium Health, formerly Carolinas HealthCare System, in Charlotte, NC. Prior to joining AMG, Anthony held positions as a urology nurse practitioner at two major hospital systems in New York City.Anthony is a member of the American Urological Association; the Certification Board for Urologic Nurses and Associates, where he has served as President and previously chaired multiple committees; the Society of Urologic Nurses and Associates; the American Association of Nurse Practitioners; and the American Nurses Association. He is a published author in nursing textbooks and in multiple peer-reviewed medical and nursing journals, and serves as a manuscript reviewer for Urologic Nursing, the International Journal of STD & AIDS, and LGBT Health. Mr. Lutz is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Carbuncle, and Boils. Mr. Lutz is board certified in American Academy Of Nurse Practitioners and American Board Of Urological Nurses And Associates.